Posters

Combined treatment of massive acute subretinal haemorrhage with intravitreal recombined tissue plasminogen activator, expansile gas and bevacizumab: case report.

Poster Details

First Author: A.Espino Garcia SPAIN

Co Author(s):                                 

Abstract Details



Purpose:

Massive subfoveal haemorrhage remains as an urgent challenge which may be managed with different procedures. In the following case report, we are presenting an easy, safe, and efficacious technique to be done in such cases.

Setting:

Hospital Universitario de Fuenlabrada

Methods:

A 71 years old male was seen in our emergency room after loss of vision on his right eye a few hours before then. He had been previously diagnosed with a choroidal neovascularization in the same eye, which had been inactive for the previous 7 months after 3 intravitreal bevacizumab injections. Visual acuity (VA) dropped from 0.6 to 0.1. A massive subretinal haemorrhage and retinal pigment epithelium detachment was revealed after ophthalmoscopic examination. Once a neovascular subretinal membrane reactivation was suspected, it was treated with intravitreal r-TPA, sulphur hexafluoride (SF6) and bevacizumab 3 days after the previous visit.

Results:

There was an almost complete removal of submacular blood in the following 24 hours. Afterwards, a pro re nata regimen of bevacizumab injections was followed. VA was 0.5 at his last visit.

Conclusions:

In this case report, we remark the safety and efficacy of an easy and quick procedure to solve submacular haemorrhages, in which early treatment is advisable to obtaining an optimal outcome.

Back to previous
EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email: euretina@euretina.org

Privacy policyHotel Terms and Conditions Cancellation policy